521 related articles for article (PubMed ID: 19797722)
1. Proposed FDA rules on painkillers in U.S. Rile cancer community.
Brower V
J Natl Cancer Inst; 2009 Oct; 101(20):1376-7. PubMed ID: 19797722
[No Abstract] [Full Text] [Related]
2. Cancer in the developing world: Palliative care gains ground in developing countries.
Crane K
J Natl Cancer Inst; 2010 Nov; 102(21):1613-5. PubMed ID: 20966432
[No Abstract] [Full Text] [Related]
3. Cancer pain management guidelines issued for children; adult guidelines updated.
Susman E
J Natl Cancer Inst; 2005 May; 97(10):711-2. PubMed ID: 15900038
[No Abstract] [Full Text] [Related]
4. Safety alert for fentanyl buccal tablets.
U.S. Food and Drug Administration
J Pain Palliat Care Pharmacother; 2008; 22(1):47. PubMed ID: 19062355
[TBL] [Abstract][Full Text] [Related]
5. Pain, the DEA, and the impact on patients.
Rowe W
Pain Med; 2006; 7(1):86. PubMed ID: 16533206
[No Abstract] [Full Text] [Related]
6. Oncologists want FDA to rethink REMS.
Goozner M
J Natl Cancer Inst; 2010 Dec; 102(23):1748-9, 1751. PubMed ID: 21088276
[No Abstract] [Full Text] [Related]
7. Oral methadone for cancer pain: no indication of Q-T interval prolongation or torsades de pointes.
Reddy S; Fisch M; Bruera E
J Pain Symptom Manage; 2004 Oct; 28(4):301-3. PubMed ID: 15471646
[No Abstract] [Full Text] [Related]
8. They suffer in silence.
Butola S
J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):167-9. PubMed ID: 22764855
[TBL] [Abstract][Full Text] [Related]
9. StatBite: cancer pain.
J Natl Cancer Inst; 2009 Oct; 101(20):1377. PubMed ID: 19797720
[No Abstract] [Full Text] [Related]
10. Practical approaches to optimizing the effective use of opioids in cancer pain.
Amen K
ONS Connect; 2007; 22(8 Suppl):13-4. PubMed ID: 17824545
[No Abstract] [Full Text] [Related]
11. Abuse-resistant painkillers get mixed FDA response.
Waters H
Nat Med; 2011 Aug; 17(8):905. PubMed ID: 21818068
[No Abstract] [Full Text] [Related]
12. Palliative care for "Margaret".
Ryan R
J Clin Ethics; 2006; 17(4):344-8. PubMed ID: 17330728
[No Abstract] [Full Text] [Related]
13. Palliative care and hospice opioid dosing guidelines with breakthrough pain (BP) doses.
Pappagallo M; Dickerson ED; Hulka S
Am J Hosp Palliat Care; 2000; 17(6):407-13. PubMed ID: 11886043
[No Abstract] [Full Text] [Related]
14. Addressing OxyContin abuse.
FDA Consum; 2001; 35(4):3. PubMed ID: 11692884
[No Abstract] [Full Text] [Related]
15. Continuing challenges in the management of cancer pain.
Bruera E
Oncology (Williston Park); 1989 Aug; 3(8 Suppl):31-4. PubMed ID: 2484298
[TBL] [Abstract][Full Text] [Related]
16. Opioid medication management: clinician beware!
Jamison RN; Clark JD
Anesthesiology; 2010 Apr; 112(4):777-8. PubMed ID: 20216398
[No Abstract] [Full Text] [Related]
17. Cancer inpatients morphine usage: a New England survey.
Woollard L
Aust J Rural Health; 2004 Jun; 12(3):126; author reply 127. PubMed ID: 15200524
[No Abstract] [Full Text] [Related]
18. Pain management misstatements: ceiling effects, red and yellow flags.
Passik SD
Pain Med; 2006; 7(1):76-7. PubMed ID: 16533203
[No Abstract] [Full Text] [Related]
19. Ending inequities in access to effective pain relief?
Liberman J; O'Brien M; Hall W; Hill D
Lancet; 2010 Sep; 376(9744):856-7. PubMed ID: 20833289
[No Abstract] [Full Text] [Related]
20. Cancer pain demands an integrated approach.
Fine PG
J Support Oncol; 2004; 2(6):503-4. PubMed ID: 16329215
[No Abstract] [Full Text] [Related]
[Next] [New Search]
